The window for biotech IPOs remains wide open and six more companies have charged through it, raising more than $568 million in the span of 24 hours. The first was Eidos Therapeutics (NASDAQ: EIDX), which raised $106 million in its stock market debut. The San Francisco company priced its IPO late Tuesday, selling 6.25 million […]